Abstract:Hypoxia is a hallmark of solid tumors. Hypoxic cancer cells adjust their metabolic characteristics to regulate the production of cellular reactive oxygen species (ROS) and facilitate ROS‐mediated metastasis. Peroxisome proliferator‐activated receptor γ (PPARγ) is a nuclear receptor that regulates the transcription of fatty acid metabolism‐related genes that have a key role in the survival and proliferation function of hypoxic cancer cells. In the present study, mRNA expression in HepG2 cells under chemically induced hypoxia was assessed. The protein expression levels of hypoxia‐inducible factor 1α (HIF‐1α) were measured using western blotting. Following treatment with the PPARγ agonist pioglitazone, cell viability was assessed using a Cell Counting Kit‐8 assay, whilst cell proliferation and death were determined using 5‐ethynyl‐2'‐deoxyuridine incorporation staining, and calcein‐acetoxymethyl ester and propidium iodide staining, respectively. Cellular ROS production was assessed using dihydroethidium staining. Cobalt chloride was used to induce hypoxia in HepG2 cells, which was evaluated using HIF‐1α expression. The results revealed that the mRNA expression of PPARγ, CD36, acetyl‐co‐enzyme A dehydrogenase (ACAD) medium chain (ACADM) and ACAD short‐chain (ACADS) was downregulated in hypoxic HepG2 cells. The PPARγ agonist pioglitazone decreased the cell viability of hypoxic HepG2 cells by inhibiting cell proliferation and inducing cell death. Following treatment with the PPARγ agonist pioglitazone, hypoxic HepG2 cells produced excessive ROS. ROS‐mediated cell death induced by the PPARγ agonist pioglitazone was rescued with the antioxidant N‐acetyl‐L‐cysteine. The downregulated mRNA expression of PPARγ, CD36, ACADM and ACADS was not reverted by a PPARγ agonist in hypoxic HepG2 cells. By contrast, the PPARγ agonist suppressed the mRNA expression of BCL2, which was upregulated in hypoxic HepG2 cells. In summary, the PPARγ agonist stimulated excessive ROS production to inhibit cell proliferation and increase the death of hypoxic HepG2 cells by decreasing BCL2 mRNA expression, suggesting a negative association between PPARγ and BCL2 in the regulation of ROS production in hypoxic HepG2 cells.

Troglitazone Induced Apoptosis Via PPARγ Activated POX-induced ROS Formation in HT29 Cells.

Poster Session AP2: Cell Death and Survival

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

[Peroxisome Proliferator-Actived Receptor-Gamma Ligand Troglitazone Induces Apoptosis in Renal Cell Carcinoma].

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Pioglitazone Protect PC12 Cells Against Oxidative Stress Injury: Involvement of Anti-apoptotic Effect and PPARγ Activation

[Inhibitory Effects of Thiazolidinedione Upon Cytokine-Induced Apoptosis in Pancreatic Beta-Cell Line].

Pioglitazone, a peroxisome proliferator‐activated receptor γ agonist, induces cell death and inhibits the proliferation of hypoxic HepG2 cells by promoting excessive production of reactive oxygen species

Troglitazone Upregulates Pten Expression And Induces The Apoptosis Of Pulmonary Artery Smooth Muscle Cells Under Hypoxic Conditions

Troglitazone Sensitizes Effect of Epirubicin on Breast Cancer Cells

Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells

Curcumin Suppresses PPARδ Expression and Related Genes in HT-29 Cells

Pioglitazone Protects PC12 Cells Against Oxidative Stress Injury: an in Vitro Study of Its Antiapoptotic Effects Via the PPARγ Pathway.

Loss of Xiap Sensitizes Colon Cancer Cells to Ppar Gamma Independent Antitumor Effects of Troglitazone and 15-Pgj2

Gene expression profile in colon cancer cells with respect to XIAP expression status

Peroxisome Proliferator-Activated Receptor Γ Ligands Induce Apoptosis of Renal Cell Carcinoma

Pioglitazone Inhibits the Expressions of P22phox and P47phox in Rat Mesangial Cells in Vitro

Troglitazone Inhibits Cell Proliferation by Attenuation of Epidermal Growth Factor Receptor Signaling Independent of Peroxisome Proliferator-Activated Receptor Γ

Effects of Peroxisome Proliferator-Activated Receptor-γ Activation on Apoptosis in Rats with Acute Pancreatitis

Trolox prevents high glucose‐induced apoptosis in rat myocardial H9c2 cells by regulating GLUT‐4 and antioxidant defense mechanism

Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner